DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2015; 140(11): 782DOI: 10.1055/s-0041-102289 Leserbrief © Georg Thieme Verlag KG Stuttgart · New York Individueller Heilversuch: Roflumilast als Anorektikum Compassionate use: roflumilast as an anorectic drug Peter Pommer 1 Abteilung für Pneumologie, Gesundheitszentrum Oberammergau › Author Affiliations Recommend Article Abstract Buy Article Schlüsselwörter SchlüsselwörterAdipositas - Roflumilast - individueller Heilversuch Keywords Keywordsobesity - roflumilast - compassionate use Full Text References Literatur 1 Blüher M. Konservative Therapie der Adipositas – wann und wie?. Dtsch med Wochenschr 2015; 140: 24-28 2 Wouters EF, Bredenbröker D, Teichmann P et al. Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: E1720-E1725 3 Vollert S, Kaessner N, Heuser A et al. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia 2012; 55: 2779-2788
